Caspase activation and apoptosis in response to proteasome inhibitors

Cell Death and Differentiation

Volumn 12, Issue 9, 2005, Pages 1240-1254

  Henderson, C J ^a   Aleo, E ^a   Fontanini, A ^a   Maestro, R ^b   Paroni, G ^a   Brancolini, C ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Caspase; Chemotherapy; GFP; IAP; Mitochondria; Time lapse; TMRM

Indexed keywords

APOPTOSOME; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CASPASE; CASPASE 3; CASPASE 7; CASPASE 9; CISPLATIN; COLCHICINE; CYTARABINE; CYTOCHROME C; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; GEMCITABINE; IRINOTECAN; PACLITAXEL; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN BCL 2; RALTITREXED; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; TOPOTECAN; TRICHOSANTHIN; VINBLASTINE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOSOL; DEPOLARIZATION; ENZYME ACTIVATION; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARRIER PROTEINS; CASPASE 9; CASPASES; CELL DEATH; CYTOCHROMES C; CYTOSOL; ENZYME ACTIVATION; ENZYME INHIBITORS; ETOPOSIDE; GREEN FLUORESCENT PROTEINS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; MEMBRANE POTENTIALS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; PLASMIDS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-BCL-2; RETROVIRIDAE; RNA, SMALL INTERFERING; TIME FACTORS; TRANSFECTION;

EID: 23944483498     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401729     Document Type: Article

References (64)

1. Debatin K (2000) Activation of apoptosis pathways by anticancer treatment. Toxicol Lett. 112-113: 41-48
2. Makin G and Dive C (2001) Apoptosis and cancer chemotherapy. Trends Cell Biol. 11: S22-S26
3. Cryns V and Yuan J (1998) Proteases to die for. Genes Dev. 12: 1551-1570
4. Boatright KM and Salvesen GS (2003) Mechanisms of caspase activation. Curr. Opin. Cell Biol. 15: 725-731
5. Shi Y (2004) Caspase activation: revisiting the induced proximity model. Cell 117: 855-858
6. Fischer U, Janicke RU and Schulze-Osthoff K (2003) Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 10: 76-100
7. Jiang X and Wang X (2004) Cytochrome C-mediated apoptosis. Annu. Rev. Biochem. 73: 87-106
8. Cory S, Huang DC and Adams JM (2003) The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-8607
9. Scorrano L and Korsmeyer SJ (2003) Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem. Biophys. Res. Commun. 304: 437-444
10. Salvesen GS and Duckett CS (2002) IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3: 401-410
11. Debatin KM, Poncet D and Kroemer G (2002) Chemotherapy: targeting the mitochondrial cell death pathway. Oncogene 21: 8786-8803
12. Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA and Gruss P (1998) Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell 94: 727-733
13. Fearnhead HO, Rodriguez J, Govek EE, Guo W, Kobayashi R, Hannon G and Lazebnik YA (1998) Oncogene-dependent apoptosis is mediated by caspase-9. Proc. Natl. Acad. Sci. USA 95: 13664-13669
14. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM and Mak TW (1998) Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 7: 339-345
15. Lassus P, Opitz-Araya X and Lazebnik Y (2002) Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 297: 1352-1354
16. Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW and Lowe SW (1999) Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284: 156-159
17. Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM and Mak TM (1998) Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94: 739-750
18. Henderson C, Mizzau M, Paroni G, Maestro R, Schneider C and Brancolini C (2003) Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA). J. Biol. Chem. 278: 12579-12589
19. Hershko A and Ciechanover A (1998) The ubiquitin system. Ann. Rev. Biochem. 67: 425-479
20. Lee DH and Goldberg AL (1998) Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8: 397-403
21. Ekert PG, Read SH, Silke J, Marsden VS, Kaufmann H, Hawkins CJ, Gerl R, Kumar S and Vaux DL (2004) Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J. Cell Biol. 165: 835-842
22. Marsden VS, Ekert PG, Van Delft M, Vaux DL, Adams JM and Strasser A (2004) Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9. J. Cell Biol. 165: 775-780
23. Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ, Roy S, Nicholson DW, Vaux DL, Bouillet P, Adams JM and Strasser A (2002) Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 419: 634-637
24. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730
25. Bernardi P, Petronilli V, Di Lisa F and Forte M (2001) A mitochondrial perspective on cell death. Trends Biochem. Sci. 26: 112-117
26. Ly JD, Grubb DR and Lawen A (2003) The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 8: 115-128
27. Heiskanen KM, Bhat MB, Wang HM, Ma J and Nieminen AL (1999) Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC6 cells. J. Biol. Chem. 26: 5654-5658
28. Ricci JE, Munoz-Pinedo C, Fitzgerald P, Bailly-Maitre B, Perkins GA, Yadava N, Scheffler IE, Ellisman MH and Green DR (2004) Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 117: 773-786
29. Scorrano L, Petronilli V, Di Lisa F and Bernardi P (1999) Commitment to apoptosis by GD3 ganglioside depends on opening of the mitochondrial permeability transition pore. J. Biol. Chem. 274: 22581-22585
30. Dussmann H, Rehm M, Kogel D and Prehn JH (2003) Outer mitochondrial membrane permeabilization during apoptosis triggers caspase-independent mitochondrial and caspase-dependent plasma membrane potential depolarization: a single-cell analysis. J. Cell Sci. 116: 525-536
31. Rehm M, Dussmann H and Prehn JH (2003) Real-time single cell analysis of Smac/DIABLO release during apoptosis. J. Cell Biol. 162: 1031-1043
32. Waterhouse NJ, JGoldstein JC, von Ahsen O, Schuler M, Newmeyer DD and Green DR (2001) Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J. Cell Biol. 153: 319-328
33. Hao Y, Sekine K, Kawabata A, Nakamura H, Ishioka T, Ohata H, Katayama R, Hashimoto C, Zhang X, Noda T, Tsuruo T and Naito M (2004) Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function. Nat. Cell Biol. 6: 849-860
34. MacFarlane M, Merrison W, Bratton SB and Cohen GM (2002) Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. J. Biol. Chem. 277: 36611-36616
35. Bartke T, Pohl C, Pyrowolakis G and Jentsch S (2004) Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase. Mol Cell 14: 801-811
36. Hu S and Yang X (2003) Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO. J. Biol. Chem. 278: 10055-10060
37. Qiu XB and Goldberg AL (2005) The membrane-associated inhibitor of apoptosis protein, BRUCE/Apollon, antagonizes both the precursor and mature forms of Smac and caspase-9. J. Biol. Chem. 280: 174-182
38. Wilkinson JC, Wilkinson AS, Scott FL, Csomos RA, Salvesen GS and Duckett CS (2004) Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs): a caspase-independent mechanism for apoptotic inhibition. J. Biol. Chem. 279: 51082-51090
39. Hunter AM, Kottachchi D, Lewis J, Duckett CS, Korneluk RG and Liston P (2003) A novel ubiquitin fusion system bypasses the mitochondria and generates biologically active Smac/DIABLO. J. Biol. Chem. 278: 7494-7499
40. Chai J, Du C, Wu JW, Kyin S, Wang X and Shi Y (2000) Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 406: 855-862
41. Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri F, Huang Z and Alnemri ES (2000) Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J. Biol. Chem. 275: 36152-36157
42. Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J, Lee RA, Robbins PD, Fernandes-Alnemri T, Shi Y and Alnemri ES (2001) A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410: 112-116
43. Wu G, Chai J, Suber TL, Wu JW, Du C, Wang X and Shi Y (2000) Structural basis of IAP recognition by Smac/DIABLO. Nature 408: 1008-1012
44. Sun XM, Butterworth M, MacFarlane M, Dubiel W, Ciechanover A and Cohen GM 2004 Caspase activation inhibits proteasome function during apoptosis. Mol. Cell. 14: 81-93
45. Almond JB and Cohen GM (2002) The proteasome: a novel target for cancer chemotherapy. Leukemia 16: 433-443
46. Adams J (2004) The proteasome: a suitable antineoplastic target. Nat. Rev. Cancer 4: 349-360
47. Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S and Elliott PJ (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res. 59: 2615-2622
48. Lopes UG, Erhardt P, Yao R and Cooper GM (1997) p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272: 12893-12896
49. Marshansky V, Wang X, Bertrand R, Luo H, Duguid W, Chinnadurai G, Kanaan N, Vu N and Wu J (2001) Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells. J. Immunol. 166: 3130-3142
50. Wagenknecht B, Hermisson M, Groscurth P, Liston P, Krammer PH and Weller M (2000) Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. J. Neurochem. 75: 2288-2297
51. Dewson G, Snowden RT, Almond JB, Dyer MJ and Cohen GM (2003) Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells. Oncogene 22: 2643-2654
52. Jana NR, Dikshit P, Goswami A and Nukina N (2004) Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J. Biol. Chem. 279: 11680-11685
53. Mitsiades N, Mitsiades CS, Poulaki V, Chauhan D, Fanourakis G, Gu X, Bailey C, Joseph M, Libermann TA, Treon SP, Munshi NC, Richardson PG, Hideshima T and Anderson KC (2002) Molecular sequelae of proteasome inhibition in human multiple myeloma cells. Proc. Natl. Acad. Sci. USA 99: 14374-14379
54. Fribley A, Zeng Q and Wang CY (2004) Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells. Mol. Cell Biol. 24: 9695-9704
55. Ling YH, Liebes L, Zou Y and Perez-Soler R (2003) Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells. J. Biol. Chem. 278: 33714-33723
56. Sullivan PG, Dragicevic NB, Deng JH, Bai Y, Dimayuga E, Ding Q, Chen Q, Bruce-Keller AJ and Keller JN (2004) Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J. Biol. Chem. 279: 20699-20707
57. Yu C, Rahmani M, Dent P and Grant S (2004) The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib. Exp. Cell Res. 295: 555-566
58. Kurosu T, Fukuda T, Miki T and Miura O (2003) BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells. Oncogene 22: 4459-4468
59. Zhang HG, Wang J, Yang X, Hsu HC and Mountz JD (2004) Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene 23: 2009-2015
60. Schimmer AD, Welsh K, Pinilla C, Wang Z, Krajewska M, Bonneau MJ, Pedersen IM, Kitada S, Scott FL, Bailly-Maitre B, Glinsky G, Scudiero D, Sausville E, Salvesen G, Nefzi A, Ostresh JM, Houghten RA and Reed JC (2004) Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell 5: 25-35
61. Wang Z, Cuddy M, Samuel T, Welsh K, Schimmer A, Hanaii F, Houghten R, Pinilla C and Reed JC (2004) Cellular, biochemical, and genetic analysis of mechanism of small molecule IAP inhibitors. J. Biol. Chem. 279: 48168-48176
62. Tenev T, Marani M, McNeish I and Lemoine NR (2001) Pro-caspase-3 overexpression sensitises ovarian cancer cells to proteasome inhibitors 8: 256-264
63. Yang L, Cao Z, Yan H and Wood WC (2003) Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res. 63: 6815-6824
64. Paroni G, Mizzau M, Henderson C, Del Sal G, Schneider C and Brancolini C (2004) Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis. Mol. Biol. Cell 15: 2804-2818